Literature DB >> 33974073

Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain.

Jing Lu1,2, Man-Li Huang1,2, Jin-Hui Li3, Kang-Yu Jin1, Hai-Mei Li1, Ting-Ting Mou1,2, Rolf Fronczek4, Jin-Feng Duan1,2, Wei-Juan Xu1,2, Dick Swaab5,6, Ai-Min Bao1,2,6.   

Abstract

Hypocretin (also called orexin) regulates various functions, such as sleep-wake rhythms, attention, cognition, and energy balance, which show significant changes in schizophrenia (SCZ). We aimed to identify alterations in the hypocretin system in SCZ patients. We measured plasma hypocretin-1 levels in SCZ patients and healthy controls and found significantly decreased plasma hypocretin-1 levels in SCZ patients, which was mainly due to a significant decrease in female SCZ patients compared with female controls. In addition, we measured postmortem hypothalamic hypocretin-1-immunoreactivity (ir), ventricular cerebrospinal fluid (CSF) hypocretin-1 levels, and hypocretin receptor (Hcrt-R) mRNA expression in the superior frontal gyrus (SFG) in SCZ patients and controls We observed a significant decrease in the amount of hypothalamic hypocretin-1 ir in SCZ patients, which was due to decreased amounts in female but not male patients. Moreover, Hcrt-R2 mRNA in the SFG was decreased in female SCZ patients compared with female controls, while male SCZ patients showed a trend of increased Hcrt-R1 mRNA and Hcrt-R2 mRNA expression compared with male controls. We conclude that central hypocretin neurotransmission is decreased in SCZ patients, especially female patients, and this is reflected in the plasma.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cerebrospinal fluid; hypocretin; hypothalamus; orexin, hypocretin receptor; plasma; schizophrenia; superior frontal gyrus

Mesh:

Substances:

Year:  2021        PMID: 33974073      PMCID: PMC8379539          DOI: 10.1093/schbul/sbab042

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  2 in total

1.  Plasma Orexin-A Levels in Patients With Schizophrenia: A Systematic Review and Meta-Analysis.

Authors:  Shaoli Li; Ruili Zhang; Shaohua Hu; Jianbo Lai
Journal:  Front Psychiatry       Date:  2022-05-25       Impact factor: 5.435

Review 2.  Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction.

Authors:  Kah Kheng Goh; Cynthia Yi-An Chen; Tzu-Hua Wu; Chun-Hsin Chen; Mong-Liang Lu
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.